相关实验视频
Updated: Jun 29, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
851
在英国,针对创伤性出血引入全血成分的可行性
Josephine McCullagh1,2, Peter Basham3, Jane Davies3
1Clinical Haematology, Barts Health NHS Trust, London, UK.
Transfusion medicine (Oxford, England)
|April 5, 2024
概括
白细胞枯竭红细胞和血 (LD-RCP) 输血对于严重创伤患者来说是可行的,但浪费率很高. 低位数组O LD-RCP没有显示出血解的临床证据,这表明安全性.
科学领域:
- 输血医学 输血医学
- 紧急医疗 紧急医疗
- 血液组分疗法是一种血液组分疗法.
背景情况:
- 越来越多的人对整体血液 (WB) 输血对创伤性出血的兴趣.
- 英国白血病消耗过器限制了WB的立即可用性.
- 红细胞和血 (LD-RCP) 用作替代WB组件.
研究的目的:
- 评估LD-RCP的交付能力.
- 评估部件浪费率. 评估部件浪费率.
- 确定LD-RCP输血的安全性.
主要方法:
- 在重大出血创伤患者中,LD-RCP取代了标准红细胞 (RBC) 输血 (2018年11月 - 2020年10月).
- 该研究评估了交付能力,浪费和安全结果.
- 分析了患者的血型和临床标志物 (血红蛋白,胆红素).
主要成果:
- 交付了1208个LD-RCP单位,96.5%是"完全按时" (OTIF).
- 60.68%的单位被输血;39.3%被浪费,随着时间的推移显著减少 (p=0.001).
- 在O组和非O组患者之间,血红蛋白或胆红素水平没有显著差异.
结论:
- 国家卫生保健局血液和移植部门在提供LD-RCPOTIF方面证明了可行性.
- 高部件浪费与短的保质期和有限的利用率有关.
- 低 titre 组 O LD-RCP 单位没有显示出血解的临床证据.
相关概念视频
Introduction to Hemostasis
7.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.6K
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Blood Transfusion
552
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
552
Extrinsic and Intrinsic Pathways of Hemostasis
7.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.5K

